3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
55
Recurrence
14
Neoplasms, Plasma Cell
9
Primary Myelofibrosis
3
Polycythemia Vera
3
Neoplasms
3
Waldenstrom Macroglobulinemia
2
Plasmacytoma
2
Myeloproliferative Disorders
2
Hematologic Diseases
2
Thrombocytosis
1
Thrombocythemia, Essential
1
Smoldering Multiple Myeloma
1
Sarcoma, Kaposi
1
Sarcoma
1
Pancreatic Neoplasms
1
Neoplasms by Histologic Type
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Plasma Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Immunoglobulin Light-chain Amyloidosis
1
Hodgkin Disease
1
Glioma
1
Ependymoma
1
Central Nervous System Neoplasms
1
Interventions
Cyclophosphamide
15
romidepsin
9
Whole-Body Irradiation
9
fludarabine phosphate
8
Vincristine
8
Etoposide
8
Doxorubicin
8
Prednisone
7
Peripheral Blood Stem Cell Transplantation
7
Mycophenolic Acid
7
Brentuximab Vedotin
6
10-propargyl-10-deazaaminopterin
6
Rituximab
5
Granulocyte Colony-Stimulating Factor
5
Gemcitabine
5
Cyclosporine
5
denileukin diftitox
4
Nivolumab
4
Lenalidomide
4
mogamulizumab
3
Tacrolimus
3
Methotrexate
3
Immunohistochemistry
3
Gene Expression Profiling
3
Dexamethasone
3
Alemtuzumab
3
selinexor
2
pembrolizumab
2
pegfilgrastim
2
liposomal doxorubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, T-Cell, Peripheral
×
pomalidomide
×
Clear all
No trials found.